How to Verify a Compounding Pharmacy Before Your Peptide Ships

The short answer

To verify a compounding pharmacy, get its exact legal name and address, look it up in the license database of the state board of pharmacy where it operates (FDA's BeSafeRx page links to every state's lookup), and, if it claims to be a 503B outsourcing facility, confirm it appears on FDA's registered outsourcing facilities list. If the pharmacy is not in the state database, FDA's guidance is not to use it.

Everything below expands those three steps and explains how to read what you find. If you are still choosing a clinic, start with our list of questions to ask a peptide telehealth clinic, since the pharmacy's name is one of the answers you need first.

Step 1: Get the pharmacy's exact identity

You cannot look up "our partner pharmacy." Ask the clinic, or read your prescription label, for:

• the pharmacy's legal business name (and any "doing business as" name),
• the physical address where it compounds,
• whether it operates as a 503A pharmacy or a 503B outsourcing facility.

The 503A/503B distinction matters because the two categories run under different sections of federal law and different oversight. A 503A pharmacy compounds for individual patient prescriptions and is primarily overseen by its state board. A 503B outsourcing facility registers with FDA, follows current good manufacturing practice requirements and is inspected by FDA. Our 503A vs 503B guide explains what each can and cannot do with peptides, and this comparison of the three supply chains shows where research-use-only products sit outside both.

Step 2: Check the state board of pharmacy

FDA's BeSafeRx program has a page titled "Locate a State-Licensed Online Pharmacy." It links to the license database for each state, plus the District of Columbia, Guam, Puerto Rico and the Virgin Islands. FDA describes checking a pharmacy's license through the state board as an important step, and says that if the pharmacy isn't listed, you should not use it.

What to confirm in the state record

• Name and address match what is on your label or the clinic's answer. A different address can mean a different facility.
• License status is active, not expired, suspended, on probation or "inactive."
• License type fits what the pharmacy says it does. States label these differently, so read the type rather than assuming.
• Discipline or public actions, if the board publishes them. Many boards show orders or consent agreements on the license record.

Shipping across state lines

If the pharmacy is in another state, also look in your own state's database. Many states require out-of-state pharmacies that ship into the state to hold a nonresident license there. Your state board's lookup will show whether that pharmacy is registered to ship to you.

FDA also lists what to confirm about any online pharmacy you use: it requires a prescription, provides a physical U.S. address and phone number, and has a licensed pharmacist available to answer your questions.

Step 3: If it claims 503B status, check FDA's list

FDA publishes a table of registered human drug compounding outsourcing facilities. As of its September 30, 2026 update, the table shows, for each facility:

• name, location and contact,
• initial and most recent registration dates,
• date of the last FDA inspection,
• whether a Form FDA 483 was issued,
• whether a recall was conducted,
• the action taken based on the last inspection,
• whether the facility says it intends to compound sterile drugs from bulk drug substances (self-reported and not verified by FDA).

How to read those columns honestly

Form 483. A 483 lists observations an investigator made during an inspection. FDA's own note says it does not constitute a final agency determination of whether any condition violates the law. Treat a 483 as a reason to look further, not as a verdict.

"Not yet inspected." FDA notes that inspection timing depends on many variables. A facility that has not been inspected has not been cleared.

Registration lapses. Facilities that do not re-register and pay the annual fee are removed from the list on January 1 of the following year. A facility that was on last year's list may not be on this year's.

State actions are separate. FDA states that the table does not include state board of pharmacy actions and tells readers to check with the board in the state where the facility is located. That is why Step 2 still applies to 503B facilities.

Step 4: Match the label to the pharmacy

When the package arrives, the pharmacy label should tie back to what you verified. Look for your name, the prescriber's name, the pharmacy's name and address, a prescription number, and a beyond-use date. A pharmacy-dispensed prescription should not arrive in a bare vial with only a chemical name and a milligram figure.

Our COA guide covers lab documents, but for a prescription the pharmacy label is the first document that matters, because it shows who is responsible for what you received.

Red flags that should stop the order

What verification can't tell you

A clean license and registration tell you the pharmacy is legally allowed to operate and is subject to oversight. They do not tell you that a particular vial was made correctly, that the drug is right for you, or that a compounded product works the way an FDA-approved one does. Compounded drugs are not FDA-approved, and FDA has collected adverse event reports for compounded GLP-1 products, including reports linked to dosing errors.

Verification is the floor, not the ceiling. Pair it with a prescriber you can reach, a clear product description, and a plan for what to do if something seems wrong. If you have a reaction, see a clinician; if you suspect a product problem, report it to the pharmacy and to FDA. Our contamination and counterfeiting guide covers warning signs that go beyond licensing.

When to see a doctor: seek care promptly for injection-site infection signs, severe abdominal pain, persistent vomiting, or any allergic reaction, and bring the vial and label with you.